Enhancing Effects of Diphenyl Diselenide and Β-Hydroxy Β-Methylbutyrate Combined with Exercise on Neuroprotection, Memory, Mitochondrial Function, Muscle Function, and Inflammation Regulation in Older Adults and Age-Related Diseases

Why It Matters

If validated, the combined nutraceutical‑exercise strategy could become a low‑cost, multi‑targeted approach to counteract age‑related cognitive decline and sarcopenia, reshaping preventive health for the aging population.

Key Takeaways

• PhSe₂ provides selenium‑based antioxidant protection for neurons
• HMB stimulates muscle protein synthesis via mTOR signaling
• Exercise amplifies mitochondrial biogenesis across brain and muscle
• Combined PhSe₂‑HMB‑exercise reduces systemic inflammatory cytokines
• Synergy may delay onset of Alzheimer’s and sarcopenia

Pulse Analysis

The aging cascade is driven by intertwined pathways of oxidative stress, mitochondrial decay, and chronic inflammation, often manifesting as cognitive impairment and sarcopenia. While exercise remains the cornerstone of geriatric health, its benefits can plateau in individuals with diminished cellular resilience. Introducing targeted nutraceuticals—specifically diphenyl diselenide (PhSe₂) and β‑hydroxy β‑methylbutyrate (HMB)—offers a mechanistic complement: PhSe₂ mimics glutathione‑peroxidase activity, stabilizing redox balance and preserving neuronal membranes, whereas HMB activates mTOR and PI3K/Akt pathways to sustain muscle protein turnover and curb proteolysis. Together, they create a biochemical environment that primes cells for the adaptive signals generated by physical activity.

Recent animal models demonstrate that PhSe₂ supplementation enhances hippocampal plasticity, improves spatial memory, and attenuates neuroinflammatory markers such as TNF‑α and IL‑1β. Concurrently, HMB has been shown to boost mitochondrial biogenesis, increase ATP output, and suppress NF‑κB signaling in both skeletal and neural tissue. When paired with structured aerobic or resistance training, these compounds appear to magnify mitochondrial respiration efficiency and reduce reactive oxygen species, translating into measurable gains in endurance, strength, and cognitive test scores. The convergence of antioxidant, anti‑inflammatory, and anabolic pathways suggests a multi‑systemic protective effect that exceeds the sum of its parts.

Translating these findings into clinical practice will require well‑controlled trials that standardize dosage (e.g., 3 g/day HMB, 0.5 mg/kg PhSe₂), timing relative to exercise sessions, and longitudinal outcome measures such as VO₂ max, grip strength, and neuropsychological batteries. Biomarker‑driven stratification—using blood glutathione levels, cytokine panels, and mitochondrial DNA copy number—could personalize regimens for frail versus robust elders. If successful, this integrated approach could lower healthcare costs associated with dementia and falls, positioning PhSe₂ and HMB as accessible adjuncts to exercise in the broader strategy of healthy aging.